Clinical Trials › NCT06143514
Recruiting
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
Sponsored by TG Therapeutics, Inc.
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 16
Target enrollment
4
U.S. states
Mar 2024
Start date
Jun 2026
Expected completion
Interventions / Treatments
No intervention
Conditions studied
Relapsing Multiple Sclerosis
Where this trial is running (4 sites)
California1 site
San Francisco
Georgia1 site
Smyrna
North Carolina1 site
Wilmington
Tennessee1 site
Nashville
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.